Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 4,276,000 | 3,777,000 | 5,569,000 | 4,907,000 | 5,553,000 |
| Income taxes - deferred | -1,253,000 | -1,270,000 | -1,010,000 | -916,000 | -1,865,000 |
| Accounts receivable | -493,000 | -23,000 | 175,000 | 368,000 | -257,000 |
| Accounts payable and accrued liabilities | 241,000 | 478,000 | -124,000 | 67,000 | -87,000 |
| Other Working Capital | 1,055,000 | 957,000 | 135,000 | -332,000 | -515,000 |
| Other Operating Activity | 5,094,000 | 3,771,000 | 2,209,000 | 4,077,000 | 6,490,000 |
| Operating Cash Flow | $8,920,000 | $7,690,000 | $6,954,000 | $8,171,000 | $9,319,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,561,000 | -1,288,000 | -989,000 | -1,254,000 | -1,782,000 |
| Net Acquisitions | -220,000 | -1,725,000 | -235,000 | -282,000 | -13,590,000 |
| Purchase Of Investment | -142,000 | -571,000 | -18,000 | -46,000 | -26,000 |
| Other Investing Activity | -334,000 | 124,000 | -31,000 | -5,000 | 697,000 |
| Investing Cash Flow | $-3,257,000 | $-3,460,000 | $-1,273,000 | $-1,587,000 | $-14,701,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -199,000 | -324,000 | 302,000 | -448,000 | -145,000 |
| Debt Issued | 2,253,000 | 2,980,000 | 3,119,000 | 1,178,000 | 8,359,000 |
| Debt Repayment | -708,000 | -3,032,000 | -2,822,000 | -1,345,000 | -2,931,000 |
| Common Stock Issued | 574,000 | 681,000 | 1,006,000 | 646,000 | 73,000 |
| Common Stock Repurchased | -1,784,000 | -1,801,000 | -1,641,000 | -823,000 | -1,074,000 |
| Dividend Paid | -3,694,000 | -3,676,000 | -3,638,000 | -3,487,000 | -1,372,000 |
| Other Financing Activity | -43,000 | -8,000 | -52,000 | -72,000 | -17,000 |
| Financing Cash Flow | $-3,601,000 | $-5,180,000 | $-3,726,000 | $-4,351,000 | $2,893,000 |
| Exchange Rate Effect | -232,000 | 34,000 | -79,000 | 24,000 | 1,000 |
| Beginning Cash Position | 7,341,000 | 8,257,000 | 6,381,000 | 4,124,000 | 6,465,000 |
| End Cash Position | 9,148,000 | 7,341,000 | 8,257,000 | 6,381,000 | 4,124,000 |
| Net Cash Flow | $2,039,000 | $-950,000 | $1,955,000 | $2,233,000 | $-2,489,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,920,000 | 7,690,000 | 6,954,000 | 8,171,000 | 9,319,000 |
| Capital Expenditure | -2,772,000 | -1,557,000 | -1,398,000 | -1,612,000 | -1,782,000 |
| Free Cash Flow | 6,148,000 | 6,133,000 | 5,556,000 | 6,559,000 | 7,537,000 |